These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37248323)

  • 1. JMJD3 ablation in myeloid cells confers renoprotection in mice with DOCA/salt-induced hypertension.
    Gao Y; Yu W; Song J; Nie J; Cui Z; Wen S; Liu B; Liang H
    Hypertens Res; 2023 Aug; 46(8):1934-1948. PubMed ID: 37248323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon regulatory factor 4 deletion protects against kidney inflammation and fibrosis in deoxycorticosterone acetate/salt hypertension.
    Gao Y; Liu B; Guo X; Nie J; Zou H; Wen S; Yu W; Liang H
    J Hypertens; 2023 May; 41(5):794-810. PubMed ID: 36883469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of CXCR6 Ameliorates Kidney Inflammation and Fibrosis in Deoxycorticosterone Acetate/Salt Hypertension.
    Wu Y; An C; Jin X; Hu Z; Wang Y
    Sci Rep; 2020 Jan; 10(1):133. PubMed ID: 31924817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jmjd3/IRF4 axis aggravates myeloid fibroblast activation and m2 macrophage to myofibroblast transition in renal fibrosis.
    Liang H; Liu B; Gao Y; Nie J; Feng S; Yu W; Wen S; Su X
    Front Immunol; 2022; 13():978262. PubMed ID: 36159833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining mesenchymal stem cells with serelaxin provides enhanced renoprotection against 1K/DOCA/salt-induced hypertension.
    Li Y; Shen M; Ferens D; Broughton BRS; Murthi P; Saini S; Widdop RE; Ricardo SD; Pinar AA; Samuel CS
    Br J Pharmacol; 2021 Mar; 178(5):1164-1181. PubMed ID: 33450051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
    Krishnan SM; Ling YH; Huuskes BM; Ferens DM; Saini N; Chan CT; Diep H; Kett MM; Samuel CS; Kemp-Harper BK; Robertson AAB; Cooper MA; Peter K; Latz E; Mansell AS; Sobey CG; Drummond GR; Vinh A
    Cardiovasc Res; 2019 Mar; 115(4):776-787. PubMed ID: 30357309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anakinra reduces blood pressure and renal fibrosis in one kidney/DOCA/salt-induced hypertension.
    Ling YH; Krishnan SM; Chan CT; Diep H; Ferens D; Chin-Dusting J; Kemp-Harper BK; Samuel CS; Hewitson TD; Latz E; Mansell A; Sobey CG; Drummond GR
    Pharmacol Res; 2017 Feb; 116():77-86. PubMed ID: 27986554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal protective effects of N-acetyl-Ser-Asp-Lys-Pro in deoxycorticosterone acetate-salt hypertensive mice.
    Rhaleb NE; Pokharel S; Sharma U; Carretero OA
    J Hypertens; 2011 Feb; 29(2):330-8. PubMed ID: 21052020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL16 Deficiency Attenuates Renal Injury and Fibrosis in Salt-Sensitive Hypertension.
    Liang H; Ma Z; Peng H; He L; Hu Z; Wang Y
    Sci Rep; 2016 Jun; 6():28715. PubMed ID: 27353044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jumonji domain-containing protein-3 (JMJD3) promotes myeloid fibroblast activation and macrophage polarization in kidney fibrosis.
    An C; Jiao B; Du H; Tran M; Song B; Wang P; Zhou D; Wang Y
    Br J Pharmacol; 2023 Sep; 180(17):2250-2265. PubMed ID: 37076137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-18 (Interleukin-18) Produced by Renal Tubular Epithelial Cells Promotes Renal Inflammation and Injury During Deoxycorticosterone/Salt-Induced Hypertension in Mice.
    Thomas JM; Ling YH; Huuskes B; Jelinic M; Sharma P; Saini N; Ferens DM; Diep H; Krishnan SM; Kemp-Harper BK; O'Connor PM; Latz E; Arumugam TV; Guzik TJ; Hickey MJ; Mansell A; Sobey CG; Vinh A; Drummond GR
    Hypertension; 2021 Nov; 78(5):1296-1309. PubMed ID: 34488433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-β/Smad signaling in DOCA-salt hypertension.
    Wang Y; Wang DH
    Mol Med; 2011; 17(11-12):1204-12. PubMed ID: 21792478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detrimental role of sphingosine kinase 1 in kidney damage in DOCA-salt hypertensive model: evidence from knockout mice.
    Lyu B; Wang W; Ji XY; Ritter JK; Li N
    BMC Nephrol; 2020 May; 21(1):173. PubMed ID: 32393187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension.
    Wang Y; Zhu M; Xu H; Cui L; Liu W; Wang X; Shen S; Wang DH
    Exp Biol Med (Maywood); 2015 Sep; 240(9):1223-34. PubMed ID: 25585624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 21 attenuates salt-sensitive hypertension-induced nephropathy through anti-inflammation and anti-oxidation mechanism.
    Weng HC; Lu XY; Xu YP; Wang YH; Wang D; Feng YL; Chi Z; Yan XQ; Lu CS; Wang HW
    Mol Med; 2021 Nov; 27(1):147. PubMed ID: 34773993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic ablation and pharmacological inhibition of immunosubunit β5i attenuates cardiac remodeling in deoxycorticosterone-acetate (DOCA)-salt hypertensive mice.
    Cao HJ; Fang J; Zhang YL; Zou LX; Han X; Yang J; Yan X; Li PB; Wang HX; Guo SB; Li HH
    J Mol Cell Cardiol; 2019 Dec; 137():34-45. PubMed ID: 31629736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockout of immunoproteasome subunit β2i ameliorates cardiac fibrosis and inflammation in DOCA/Salt hypertensive mice.
    Yan W; Bi HL; Liu LX; Li NN; Liu Y; Du J; Wang HX; Li HH
    Biochem Biophys Res Commun; 2017 Aug; 490(2):84-90. PubMed ID: 28478040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of TRPV4 by dietary apigenin antagonizes renal fibrosis in deoxycorticosterone acetate (DOCA)-salt-induced hypertension.
    Wei X; Gao P; Pu Y; Li Q; Yang T; Zhang H; Xiong S; Cui Y; Li L; Ma X; Liu D; Zhu Z
    Clin Sci (Lond); 2017 Apr; 131(7):567-581. PubMed ID: 28143892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CS-3150, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, Shows Preventive and Therapeutic Effects On Renal Injury in Deoxycorticosterone Acetate/Salt-Induced Hypertensive Rats.
    Arai K; Morikawa Y; Ubukata N; Tsuruoka H; Homma T
    J Pharmacol Exp Ther; 2016 Sep; 358(3):548-57. PubMed ID: 27384074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice.
    Li Y; Chakraborty A; Broughton BRS; Ferens D; Widdop RE; Ricardo SD; Samuel CS
    Biomed Pharmacother; 2021 Dec; 144():112256. PubMed ID: 34607108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.